HMGB1 and infection: Additionally, endogenous molecules such as immunoglobulins, antithrombin, thrombomodulin, vasoactive intestinal peptide, and growth hormone-releasing peptide have demonstrated potential in reducing HMGB1-mediated inflammation in various conditions, including infections and chemical toxicity (Yang et al., 2020a; Lu et al., 2014).